NEPH vs TROW · P/E 48, rev $14.2M vs P/E 12, rev $7.09B
Nephros Inc (NEPH) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Latest reported TROW revenue for 2024-12-31 was $7.09B. Net income was $2.14B. Revenue was up 9.8% from 2023-12-31 to 2024-12-31. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
NEPH currently screens at market cap $40.9M and trailing P/E 48.3. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the NEPH and TROW stock pages for the full models.
Not investment advice.